Prometheus: from legend to the real liver support therapy.

作者: K. Rifai , C. Tetta , C. Ronco

DOI: 10.1177/039139880703001002

关键词:

摘要: Background: A large number of patients develop liver disease that may evolve into progressive chronic failure. Artificial support systems (e.g., MARS and Prometheus) are considered in the framework steady increase who could possibly benefit from these blood purification devices. Albumin dialysis adsorption now two integrated concepts. The present know-how enabling us to appropriately modify several intrinsic characteristics adsorbents - e.g., their chemical nature, particle pore size distribution, as well a larger surface offered has helped better fine-tuning improve kinetics flow specifically for intended clinical application. These properties together with an improved biocompatibility have made possible development adsorptive techniques which clearances total removal rates target compound would be unthinkable conventional hemodialysis or hemofiltration. Several already available commercially treatment sepsis septic shock acute failure, but controlled studies end points still lacking.

参考文章(18)
Antonio Santoro, Elena Mancini, Emiliana Ferramosca, Stefano Faenza, Liver Support Systems Contributions To Nephrology. ,vol. 156, pp. 396- 404 ,(2007) , 10.1159/000102130
B. K. I. Meijers, P. Verhamme, F. Nevens, M. F. Hoylaerts, B. Bammens, A. Wilmer, J. Arnout, Y. Vanrenterghem, P. Evenepoel, Major coagulation disturbances during fractionated plasma separation and adsorption. American Journal of Transplantation. ,vol. 7, pp. 2195- 2199 ,(2007) , 10.1111/J.1600-6143.2007.01909.X
Kinan Rifai, Carsten Hafer, Jens Rosenau, Christoph Athmann, Hermann Haller, Michael Peter Manns, Danilo Fliser, Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus). Scandinavian Journal of Gastroenterology. ,vol. 41, pp. 1212- 1217 ,(2006) , 10.1080/00365520600610154
James F. Winchester, Jeffrey Silberzweig, Claudio Ronco, Viktoria Kuntsevich, Daniel Levine, Tom Parker, John A. Kellum, Jamie A. Salsberg, Peter Quartararo, Nathan W. Levin, Sorbents in acute renal failure and end-stage renal disease: middle molecule and cytokine removal. Blood Purification. ,vol. 22, pp. 73- 77 ,(2004) , 10.1159/000074926
Ciro Tetta, Rinaldo Bellomo, Alessandra Brendolan, Pasquale Piccinni, Antonio Digito, Maurizio Dan, Marco Irone, Gerhard Lonnemann, Donatella Moscato, Juan Buades, Giuseppe La Greca, Claudio Ronco, Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill Kidney International. ,vol. 56, pp. 15- 19 ,(1999) , 10.1046/J.1523-1755.56.S72.16.X
A. Skwarek, M. Grodzicki, P. Nyckowski, M. Kotulski, K. Zieniewicz, B. Michalowicz, W. Patkowski, I. Grzelak, A. Paczkowska, D. Giercuszkiewicz, J. Sańko-Resmer, L. Pączek, M. Krawczyk, The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results. International congress of the Polish Transplantation Society. ,vol. 38, pp. 209- 211 ,(2006) , 10.1016/J.TRANSPROCEED.2005.12.011
Pieter Evenepoel, Wim Laleman, Alexander Wilmer, Kathleen Claes, Bart Maes, Dirk Kuypers, Bert Bammens, Frederik Nevens, Yves Vanrenterghem, Detoxifying Capacity and Kinetics of Prometheus® – A New Extracorporeal System for the Treatment of Liver Failure Blood Purification. ,vol. 23, pp. 349- 358 ,(2005) , 10.1159/000086885
Peter Krisper, Rudolf E Stauber, Technology Insight: artificial extracorporeal liver support—how does Prometheus® compare with MARS®? Nature Clinical Practice Nephrology. ,vol. 3, pp. 267- 276 ,(2007) , 10.1038/NCPNEPH0466
Pieter Evenepoel, Wim Laleman, Alexander Wilmer, Kathleen Claes, Dirk Kuypers, Bert Bammens, Frederik Nevens, Yves Vanrenterghem, Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Artificial Organs. ,vol. 30, pp. 276- 284 ,(2006) , 10.1111/J.1525-1594.2006.00215.X